本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Editas Medicine, Inc.

3.28
+0.28009.33%
盤前3.300.0200+0.61%05:02 EDT
成交量:421.25萬
成交額:1,360.03萬
市值:5.02億
市盈率:-4.49
高:3.33
開:3.05
低:3.05
收:3.00
52周最高:4.54
52周最低:1.66
股本:1.53億
流通股本:1.15億
量比:1.04
換手率:3.66%
股息:- -
股息率:- -
每股收益(TTM):-0.7307
每股收益(LYR):-1.8036
淨資產收益率:-118.82%
總資產收益率:-23.29%
市淨率:4.77
市盈率(LYR):-1.82

資料載入中...

2022/11/02

重要事件披露

8-K - Current report
2022/11/02

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/08/03

重要事件披露

8-K - Current report
2022/08/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/06/13

重要事件披露

8-K - Current report
2022/05/04

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/05/04

重要事件披露

8-K - Current report
2022/04/14

重要事件披露

8-K - Current report
2022/03/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/24

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/02/24

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/02/24

重要事件披露

8-K - Current report
2022/02/14

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/09

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/07

重要事件披露

8-K - Current report
2022/02/04

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/11/15

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/11/10

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/10/28

持股變動聲明

3 - Initial statement of beneficial ownership of securities